Exagen releases largest comparative utility study in lupus diagnostics confirming avise® lupus delivers unparalleled utility
San diego, july 05, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced new robust, real-world evidence confirming avise® testing enables decisive clinical action in the differential diagnosis for lupus. the complement activation products vs. standard ana testing: treatment outcomes, diagnosis, and economic impact in systemic lupus erythematosus (capstone) study is the largest comparative utility study in lupus diagnosis and was published in the journal of managed care & specialty pharmacy. the study leveraged multiple external databases encompassing electronic health records and linked insurance claims data on nearly 50,000 patient tests with avise or standard of care labs from hundreds of rheumatologists across the u.s., comparing diagnosis, treatment, and cost of care outcomes for new patients tested with avise lupus and those tested with a traditional ana (tana) approach, including specific autoantibodies. the findings revealed that the avise lupus test is more clinically effective, both for patients who test positive and those who test negative, as compared to the current standard of care.
XGN Ratings Summary
XGN Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission